Swiss partner to fight bowel disease

Israel’s CytoReason (see here previously) is partnering Swiss multinational Ferring to find new treatments for patients with inflammatory bowel disease (IBD). CytoReason’s AI technology will enable the joint building of models of diseased cells on which therapies will be tested.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *